Related content

A CD44⁻/CD24⁺ phenotype is a poor prognostic marker in early invasive breast cancer

By Ahmed Mohamed   Aleskandarany Mohammed   Rakha Emad   Moustafa Radwa   Benhasouna Ahmed   Nolan Christopher   Green Andrew   Ilyas Mohammad   Ellis Ian  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 979-995

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of Cdk2 kinase activity selectively targets the CD44+/CD24-/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells

By                      

International Journal of Oncology, Vol. 45, Iss. 3, 2014-01 ,pp. : 1193-1199

Spandidos Publications

Access to resources Recommend Favorite

Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer

By                      

Oncology Reports, Vol. 27, Iss. 5, 2012-01 ,pp. : 1599-1605

Spandidos Publications

Access to resources Recommend Favorite

Prognostic Value of Immunohistochemically Detected CD44 Isoforms CD44v5, CD44v7-8 in Human Breast Cancer

By Tempfer C.   Losch A.   Heinzl H.   Hausler G.   Hanzal E.   Kolbl H.   Breitenecker G.   Kainz C.  

European Journal of Cancer, Vol. 32, Iss. 11, 1996-10 ,pp. : 2023-2025

Elsevier

Access to resources Recommend Favorite

CD44s and CD44v6 in Diagnosis and Prognosis of Human Bladder Cancer

By Omran Ola M.   Ata Hesham S.  

Ultrastructural Pathology, Vol. 36, Iss. 3, 2012-05 ,pp. : 145-152

Informa Healthcare

Access to resources Recommend Favorite